共 79 条
[1]
Alibhai SM(2006)Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review Crit Rev Oncol Hematol 60 201-215
[2]
Gogov S(1997)Long-term effect of testosterone therapy on bone mineral density in hypogonadal men J Clin Endocrinol Metab 82 2386-2390
[3]
Alibhai Z(2005)Effect of testosterone replacement on trabecular architecture in hypogonadal men J Bone Miner Res 20 1785-1791
[4]
Behre HM(2009)Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha FASEB J 23 232-240
[5]
Kliesch S(2010)Sex steroids and the male skeleton: a tale of two hormones Trends Endocrinol Metab 21 89-95
[6]
Leifke E(2003)GnRH agonists and antagonists in cancer therapy Curr Med Chem Anticancer Agents 3 399-410
[7]
Benito M(2006)Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men J Clin Endocrinol Metab 91 3908-3915
[8]
Vasilic B(2005)Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer J Clin Endocrinol Metab 90 6410-6417
[9]
Wehrli FW(2008)Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy J Clin Oncol 26 4426-4434
[10]
Callewaert F(2009)Drug treatment of paraphilic and nonparaphilic sexual disorders Clin Ther 31 1-31